Boehringer Ingelheim Animal Health España, S.A.U.

Company Premium

La división veterinaria de Boehringer Ingelheim España inició su actividad en 1971 aportando soluciones innovadoras para prevenir, curar y tratar las enfermedades de los animales. En el caso del porcino (43% del total de la facturación), nuestro principal foco consiste en la producción de vacunas para mejorar el bienestar de los animales y así trabajar en la obtención de un futuro más saludable para todos.

Send message
Three months pigs with PCV2-SD. Note the marked spine, indicative of growth retardation, and body pallor

The challenge of Porcine Circovirus type 2 (PCV2) intra-specific taxonomic classification

All available vaccines in the European and North-American market are based on PCV2a genotype, while the most prevalent ones are PCV2b and PCV2d ones. Although significant level of cross-protection among these three genotypes has been demonstrated, it would be interesting to assess if vaccine efficiency would be equivalent in front of all these different genotypes.

Vaccination

How PCV2 vaccines work

19-Jan-2016

Despite not having a consistent post-vaccination serological reaction, vaccinated animals behave differently from unvaccinated animals under field conditions.The article explains why vaccines offer protection.

Serum and oral fluid PRRSV qRT-PCR results by post-inoculation week

Oral fluids in PRRS diagnosis

29-May-2015

Diagnosis in oral fluids is indicated for the control of replacements on arrival and after the adaptation process, and of the different production batches, especially risk subpopulations such as animals with a slow growth rate.

Contact:

Contact us using the following form.